Filing Details
- Accession Number:
- 0001327763-14-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-27 16:25:21
- Reporting Period:
- 2014-08-24
- Filing Date:
- 2014-08-27
- Accepted Time:
- 2014-08-27 16:25:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-08-24 | 25,507 | $43.55 | 499,710 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-08-26 | 60,000 | $0.00 | 559,710 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Acquisiton | 2014-08-26 | 2,268 | $0.00 | 2,268 | $44.09 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2014-08-26 | 147,732 | $0.00 | 147,732 | $44.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,268 | 2024-08-26 | No | 4 | A | Direct | |
| 147,732 | 2024-08-26 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 100,000 | Indirect | by Trust |
Footnotes
- Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- These shares represent restricted stock units and will be settled in common stock upon vesting.
- Restricted stock units shall vest in full three (3) years from grant date.
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- Shares shall vest at a rate of 25% one year from grant date and monthly thereafter until all shares are fully vested four years from grant date.
Billionaire Hedge Funds
